BioCentury | Jan 20, 2014
Company News

Axxam, Hit Discovery Constance, Lead Discovery Center, Centre for Drug Design and Discovery (CD3) supply/service, high throughput screening news

...JV is split. Hit Discovery is using equipment from the former compound management facilities of Altana...
BioCentury | Sep 6, 2010
Company News

BTG, Nycomed sales and marketing update

...of the Altana Pharma unit from Altana AG (Xetra:ALT, Wesel, Germany). In 1997, Protherics granted Altana...
BioCentury | Apr 12, 2010
Regulation

Forest Runs into Tree

...filed in 1999 by Altana AG , and became Nycomed 's when it acquired Altana's Altana...
...Pharma unit in September 2006 (see BioCentury, Sept. 25, 2006). Based on feedback from FDA, Altana...
...significant reductions in exacerbations. A post hoc analysis of the 111 and 112 trials led Altana...
BioCentury | Nov 23, 2009
Product Development

Nycomed Holding its Breath

...from Altana AG . Companies and Institutions Mentioned Alcon Laboratories Inc. (NYSE:ACL), Fort Worth, Texas Altana...
BioCentury | Nov 16, 2009
Clinical News

Daxas roflumilast: Additional Phase III data

...17). Nycomed gained the product through its 2006 acquisition of the Altana Pharma unit from Altana...
BioCentury | Nov 16, 2009
Clinical News

Daxas roflumilast: Additional Phase III data

...17). Nycomed gained the product through its 2006 acquisition of the Altana Pharma unit from Altana...
BioCentury | Nov 16, 2009
Clinical News

Daxas roflumilast: Additional Phase III data

...17). Nycomed gained the product through its 2006 acquisition of the Altana Pharma unit from Altana...
BioCentury | Nov 16, 2009
Clinical News

Daxas roflumilast: Additional Phase III data

...17). Nycomed gained the product through its 2006 acquisition of the Altana Pharma unit from Altana...
BioCentury | Sep 7, 2009
Clinical News

Daxas roflumilast: Additional Phase III data

...17). Nycomed gained the product through its 2006 acquisition of the Altana Pharma unit from Altana...
BioCentury | Sep 7, 2009
Clinical News

Daxas roflumilast: Additional Phase III data

...17). Nycomed gained the product through its 2006 acquisition of the Altana Pharma unit from Altana...
Items per page:
1 - 10 of 206
BioCentury | Jan 20, 2014
Company News

Axxam, Hit Discovery Constance, Lead Discovery Center, Centre for Drug Design and Discovery (CD3) supply/service, high throughput screening news

...JV is split. Hit Discovery is using equipment from the former compound management facilities of Altana...
BioCentury | Sep 6, 2010
Company News

BTG, Nycomed sales and marketing update

...of the Altana Pharma unit from Altana AG (Xetra:ALT, Wesel, Germany). In 1997, Protherics granted Altana...
BioCentury | Apr 12, 2010
Regulation

Forest Runs into Tree

...filed in 1999 by Altana AG , and became Nycomed 's when it acquired Altana's Altana...
...Pharma unit in September 2006 (see BioCentury, Sept. 25, 2006). Based on feedback from FDA, Altana...
...significant reductions in exacerbations. A post hoc analysis of the 111 and 112 trials led Altana...
BioCentury | Nov 23, 2009
Product Development

Nycomed Holding its Breath

...from Altana AG . Companies and Institutions Mentioned Alcon Laboratories Inc. (NYSE:ACL), Fort Worth, Texas Altana...
BioCentury | Nov 16, 2009
Clinical News

Daxas roflumilast: Additional Phase III data

...17). Nycomed gained the product through its 2006 acquisition of the Altana Pharma unit from Altana...
BioCentury | Nov 16, 2009
Clinical News

Daxas roflumilast: Additional Phase III data

...17). Nycomed gained the product through its 2006 acquisition of the Altana Pharma unit from Altana...
BioCentury | Nov 16, 2009
Clinical News

Daxas roflumilast: Additional Phase III data

...17). Nycomed gained the product through its 2006 acquisition of the Altana Pharma unit from Altana...
BioCentury | Nov 16, 2009
Clinical News

Daxas roflumilast: Additional Phase III data

...17). Nycomed gained the product through its 2006 acquisition of the Altana Pharma unit from Altana...
BioCentury | Sep 7, 2009
Clinical News

Daxas roflumilast: Additional Phase III data

...17). Nycomed gained the product through its 2006 acquisition of the Altana Pharma unit from Altana...
BioCentury | Sep 7, 2009
Clinical News

Daxas roflumilast: Additional Phase III data

...17). Nycomed gained the product through its 2006 acquisition of the Altana Pharma unit from Altana...
Items per page:
1 - 10 of 206